Alexandra Gardiner has joined EMAlternatives as chief financial officer. She previously served as vice president of finance for The Rock Greek Group, a $3.5 billion hedge fund-of-funds manager. www.emalternatives.com
Misti Ushio has joined Harris & Harris Group Inc. as an associate in the firm's New York office. She previously managed nanotech and materials science invention and patent portfolios for Columbia University. www.tinytechvc.com
Wachovia Corp. has implemented a reorganization, which includes financial sponsors chief Jonathan Weiss now also overseeing corporate finance. www.wachovia.com
Metabolex Inc., a Hayward, Calif.�based drug company focused on diabetes and other metabolic disorders, has raised $32 million in Series D funding. MPM BioEquities led the deal, and was joined by fellow new investors AllianceBernstein, Deerfield Management, T. Rowe Price. Return backers include Alta Partners, Bay City Capital, Biotech Turnaround Fund, Birchmere Ventures, Johnson & […]
Bioniche Pharma Group Ltd., an Ireland
The Wicks Group of Cos. has retained Credit Suisse Securities to explore strategic alternatives for horse-racing content provider Daily Racing Form LLC, including a possible sale. www.drf.com
Optinuity Inc., a Bethesda, Md.-based provider of IT process automation software for data center management, has raised $6 million in Series B funding. Edison Ventures led the deal, and was joined by Series A backers New Enterprise Associates, Venrock Associates and Mid-Atlantic Venture Funds. Optinuity has raised $12.5 million in total VC funding since 2004. […]
SurgRx Inc., a Redwood City, Calif.-based developer of laparoscopic vessel fusion tools for surgical hemostasis, has raised $20 million in Series F funding. Hedge fund Magnetar Capital Return was joined by return backers Alta Partners, New Enterprise Associates, California Technology Ventures, Prospect Venture Partners and Trellis Health Ventures. The company has raised around $63 million […]
Emotive Communications Inc., an Encino, Calif.-based developer of interactive ringtone technology for 3G, 4G and VoIP services, has raised $7.7 million in first-round funding. Participants included D.E. Shaw, Bertelsmann Digital Media Investments, Warner Music Group and unidentified angels. www.emotive.com
PTC Therapeutics Inc., a South Plainfield, N.J.-based drug company focused on post-transcriptional control mechanisms, has withdrawn its $86.25 million IPO filing, citing “market conditions.” The company had originally filed in March 2006, with Morgan Stanley and JPMorgan serving as lead underwriters. PTC has raised over $143 million in total VC funding since its 1998 inception, […]